相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Evaluation and Management of Pulmonary Arterial Hypertension in Congenital Heart Disease
Hassaan B Arshad et al.
Methodist DeBakey cardiovascular journal (2021)
Pulmonary Arterial Hypertension
Paul M. Hassoun
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances
Bradley A. Maron et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
The prognostic significance of survivin expression in patients with HNSCC: a systematic review and meta-analysis
Liu-qing Zhou et al.
BMC CANCER (2021)
Sanguinarine Reverses Pulmonary Vascular Remolding of Hypoxia-Induced PH via Survivin/HIF1α-Attenuating Kv Channels
Fenling Fan et al.
FRONTIERS IN PHARMACOLOGY (2021)
Survivin as a biological biomarker for diagnosis and therapy
Yuming Li et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2021)
Role of Survivin in Bladder Cancer: Issues to Be Overcome When Designing an Efficient Dual Nano-Therapy
Maria Arista-Romero et al.
PHARMACEUTICS (2021)
Vascular Remodeling in Pulmonary Arterial Hypertension: The Potential Involvement of Innate and Adaptive Immunity
Rachid Tobal et al.
FRONTIERS IN MEDICINE (2021)
LncRNA PAXIP1-AS1 fosters the pathogenesis of pulmonary arterial hypertension via ETS1/WIPF1/RhoA axis
Rong Song et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma
Fengzhi Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Role of Long Non-Coding RNAs in Pulmonary Arterial Hypertension
Yun Han et al.
CELLS (2021)
Prognostic Value of Survivin in Nasopharyngeal Carcinoma: A Systematic Review and Meta-analysis
Wenji Xie et al.
JOURNAL OF CANCER (2021)
The survivin molecule as a double-edged sword in cellular physiologic and pathologic conditions and its role as a potential biomarker and therapeutic target in cancer
Atieh Rafatmanesh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Pathobiology of pulmonary artery hypertension: role of long non-coding RNAs
Kashif Rafiq Zahid et al.
CARDIOVASCULAR RESEARCH (2020)
Restoring apoptosis dysregulation using survivin inhibitor in nasopharyngeal cancer
Junli Shi et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2020)
Modeling of Hypervolemia in Pulmonary Circulation in Rats Changes the Structure of NO-Mediated Relaxation of Pulmonary Arteries
M. P. Davydova
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2020)
YM155 Reverses Cabazitaxel Resistance in Castration-resistant Prostate Cancer by Reducing Survivin Expression
Takeshi Miyao et al.
ANTICANCER RESEARCH (2020)
Pediatric Pulmonary Arterial Hypertension
Benjamin S. Frank et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2020)
Emerging Effects of Sepantronium Bromide (YM155) on MOLT-4 Cell Line Apoptosis Induction and Expression of Critical Genes Involved in Apoptotic Pathways
Kobra Shojaei Moghadam et al.
ADVANCED PHARMACEUTICAL BULLETIN (2020)
Anti-apoptotic proteins in the autophagic world: an update on functions of XIAP, Survivin, and BRUCE
Chun Hei Antonio Cheung et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
Survivin overexpression in head and neck squamous cell carcinomas as a new therapeutic target
M. A. Frassanito et al.
ONCOLOGY REPORTS (2019)
The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
Michael G. Katz et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2019)
Survivin a pivotal antiapoptotic protein in rheumatoid arthritis
Parisa Zafari et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Focus on Early Events: Pathogenesis of Pulmonary Arterial Hypertension Development
Olga Rafikova et al.
ANTIOXIDANTS & REDOX SIGNALING (2019)
Sepantronium Bromide (YM155), A Small Molecule Survivin Inhibitor, Promotes Apoptosis by Induction of Oxidative Stress, Worsens the Behavioral Deficits and Develops an Early Model of Toxic Demyelination: In Vivo and In-Silico Study
Samaneh Reiszadeh-Jahromi et al.
NEUROCHEMICAL RESEARCH (2019)
d-a-Tocopheryl Polyethylene Glycol 1000 Succinate and a small-molecule Survivin suppressant synergistically induce apoptosis in SKBR3 breast cancer cells
Christiana M. Neophytou et al.
SCIENTIFIC REPORTS (2019)
Survivin as a diagnostic and therapeutic marker for thyroid cancer
Mohammad-Reza Mahmoudian-Sani et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Congenital Heart Disease and Neurodevelopment: Clinical Manifestations, Genetics, Mechanisms, and Implications
Sarah N. Nattel et al.
CANADIAN JOURNAL OF CARDIOLOGY (2017)
YM155, a selective survivin inhibitor, reverses chronic hypoxic pulmonary hypertension in rats via upregulating voltage-gated potassium channels
Zaiwen Fan et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2015)
Survivin - The inconvenient IAP
Dario C. Altieri
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
Inhibitory effect of survivin-targeting small interfering RNA on gastric cancer cells
Y. H. Li et al.
GENETICS AND MOLECULAR RESEARCH (2014)
Interleukin Enhancer-binding Factor 3/NF110 Is a Target of YM155, a Suppressant of Survivin
Naoto Nakamura et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Gene expression profile in flow-associated pulmonary arterial hypertension with neointimal lesions
Mirjam E. van Albada et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2010)
Novel Approaches to Treat Experimental Pulmonary Arterial Hypertension: A Review
S. Umar et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Pathogenic mechanisms of pulmonary arterial hypertension
Stephen Y. Chan et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Treprostinil in advanced experimental pulmonary hypertension: Beneficial outcome without reversed pulmonary vascular remodeling
Mirjam E. van Albada et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)
The role of increased pulmonary blood flow in pulmonary arterial hypertension
ME van Albada et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells
L You et al.
ONCOGENE (2004)
Effect of a surgical aortocaval fistula on mono crotaline-induced pulmonary hypertension
T Nishimura et al.
CRITICAL CARE MEDICINE (2003)